<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1142</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15489166</PubmedId>
            <Abstract>Peptides bind to class II major histocompatibility complex (MHC) proteins in an extended conformation. Pockets in the peptide binding site spaced to accommodate peptide side chains at the P1, P4, P6, and P9 positions have been previously characterized and help to explain the obtained peptide binding specificity. However, two peptides differing only at P10 have significantly different binding affinities for HLA-DR1. The structure of HLA-DR1 in complex with the tighter binding peptide shows that the peptide binds in the usual polyproline type II conformation, but with the P10 residue accommodated in a shallow pocket at the end of the binding groove. HLA-DR1 variants with polymorphic residues at these positions were produced and found to exhibit different side chain specificity at the P10 position. These results define a new specificity position in HLA-DR proteins.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>1395-402</ArticlePages>
            <ArticleTitle>A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Zavala-Ruiz</LastName>
                    <ForeName>Zarixia</ForeName>
                </Author>
                <Author>
                    <LastName>Strug</LastName>
                    <ForeName>Iwona</ForeName>
                </Author>
                <Author>
                    <LastName>Anderson</LastName>
                    <ForeName>Matthew W</ForeName>
                </Author>
                <Author>
                    <LastName>Gorski</LastName>
                    <ForeName>Jack</ForeName>
                </Author>
                <Author>
                    <LastName>Stern</LastName>
                    <ForeName>Lawrence J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</Affiliations>
            <ArticleChemicalList>HLA-DR1 Antigen;Histocompatibility Antigens Class II;Peptide Fragments</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Amino Acid Substitution(genetics); Dose-Response Relationship, Drug; Genetic Variation; HLA-DR1 Antigen(chemistry; genetics; metabolism); Histocompatibility Antigens Class II(chemistry; genetics; metabolism); Molecular Sequence Data; Peptide Fragments(chemistry; genetics; metabolism); Polymorphism, Genetic; Protein Binding(genetics; physiology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>11</Volume>
                <Issue>10</Issue>
                <Title>Chemistry &amp; biology</Title>
                <Issn>1074-5521</Issn>
                <MedlineTa>Chem Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATPLLLSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>135438</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1769179</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1 with a 15-fold higher affinity compared to peptide AAYSDQATPLLGSPR with a Gly substitution at position 12, which occupies the P10 pocket.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1, Figure 2 and Supplemental data</LocationOfData>
                        <MhcBindingId>1493063</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.4</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>There are two MHC/Epitope complexes in the asymmetric unit. PDB chains for each complex are: Complex I : α-chain: A, β-chain: B, epitope chain: C. Complex II : α-chain: D, β-chain: E, epitope chain: F. Clear electron density was found for: all MHC residues apart from a disordered loop away from the peptide binding site, epitope residues 3-12, excluding L9 residue side chain and the terminal methyl groups of the L11 residue side chain. The epitope residues outside the binding groove were disordered.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1T5W</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11, S12;</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>[| P-2: A0; P-1: A1; P1: Y2; P2: S3; P3: D4; P4: Q5; P5: A6; P6: T7; P7: P8; P8: L9; P9: L10; P10: L11; P12: S12; |] Very few details about the interacting residues are mentioned in the paper. The available information on MHC-Epitope interactions is given below: MHC residues A: R76; and B: P56, D57, Y60; are the main residues that form pocket 10. Epitope residue P10: L11 is substantially buried in the P10 pocket.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11, S12;</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ; B: ;</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1220.0</ContactAreaForEpitope>
                                <ContactAreaForMhc>850.0</ContactAreaForMhc>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Q9, E11, F22, F24, I31, F32, W43, F51, A52, S53, F54, G58, N62, V65, D66, N69, I72, M73, R76; B: W9, L11, F13, P56, D57, Y60, W61, Q70, R71, A74, Y78, H81, N82, V85, G86, F89</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1272.1</ContactAreaForEpitope>
                                <ContactAreaForMhc>863.3</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1, Figure 2 and Supplemental data</LocationOfData>
                        <MhcBindingId>1493260</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The crystal structure contains the MHC/epitope complex bound to the superantigen (SAG) staphylococcal enterotoxin type C3, variant 3B2 (SEC3-3B2). SAG PDB chain is D. This SAG has been used previously to facilitate crystallization of HLA-DR alleles. Clear electron density was found for: all MHC residues apart from a disordered loop away from the peptide binding site, epitope residues 3-12, excluding L9 residue side chain and the terminal methyl groups of the L11 residue side chain. The epitope residues outside the binding groove were disordered.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1T5X</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11, S12;</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>[| P-2: A0; P-1: A1; P1: Y2; P2: S3; P3: D4; P4: Q5; P5: A6; P6: T7; P7: P8; P8: L9; P9: L10; P10: L11; P12: S12; |] The SAG molecule contacts the MHC α chain, outside of the peptide-binding site and does not interact with the epitope. Very few details about the interacting residues are mentioned in the paper. The available information on MHC-Epitope interactions is given below: MHC residues A: R76; and B: P56, D57, Y60; are the main residues that form pocket 10. Epitope residue P10: L11 is substantially buried in the P10 pocket.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11, S12;</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ; B: ;</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1220.0</ContactAreaForEpitope>
                                <ContactAreaForMhc>850.0</ContactAreaForMhc>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: A0, A1, Y2, S3, D4, Q5, A6, T7, P8, L9, L10, L11;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Q9, E11, F24, I31, F51, A52, S53, F54, N62, V65, D66, N69, I72, M73, R76; B: L11, F13, P56, D57, Y60, W61, Q70, R71, A74, Y78, H81, N82, V85, G86, F89</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1236.4</ContactAreaForEpitope>
                                <ContactAreaForMhc>877.4</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATPLLGSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>135437</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1769182</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1 with a 15-fold lower affinity compared to peptide AAYSDQATPLLLSPR with a Gly substitution at position 12, which occupies the P10 pocket.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLYSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135436</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769183</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>200.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785128</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785129</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785130</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785131</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>46100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLFSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135421</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769184</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>300.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785132</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785133</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>7700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785134</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785135</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLASPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135417</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769185</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>900.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785136</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>34200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785137</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785138</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785139</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>61200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLKSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135425</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769186</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785140</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785141</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>8400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785142</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785143</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLGSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135422</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769187</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1100.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785144</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785145</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785146</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785147</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>14400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLTSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135433</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769188</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1600.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785150</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785151</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785148</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785149</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLLSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135426</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785152</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>10200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785153</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785154</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>15600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785155</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769189</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1800.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLESPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135420</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785156</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785157</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785158</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1785159</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769190</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3200.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Amongst the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLMSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135427</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786636</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786637</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769191</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3300.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Amongst the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786634</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4900.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786635</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>12000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLWSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135435</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786638</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786639</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786640</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>8400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786641</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769192</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5600.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLQSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135430</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786642</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786643</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>23300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786644</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>9100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786645</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769193</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5700.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLDSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135419</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786647</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>16700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786648</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786649</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>10400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786646</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769194</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>7900.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLCSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135418</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786650</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>18100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786651</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786652</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>28200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786653</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>20900.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769195</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11500.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLISPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135424</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786656</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>49200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786657</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>27400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786658</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>10100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786659</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>50600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769196</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11600.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLRSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135431</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786660</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786661</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>57500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786662</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>41400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786663</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>68200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769197</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>21000.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLVSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135434</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786664</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>28600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786665</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786666</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786667</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>26000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769198</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>22700.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLHSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135423</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786668</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>29600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769199</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>22900.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786669</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>63600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786670</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>35500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786671</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLSSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135432</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769200</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>23000.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786672</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786673</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786674</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>17000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786675</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLNSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135428</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769201</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>26700.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786676</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>16800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786677</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786678</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>45600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786679</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>10400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLLPSPR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLGSPR</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>63</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>135429</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769202</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>29200.0</QuantitativeMeasurement>
                            <AssayComments>The epitope bound to HLA-DR1. Among the 20 possible amino acids substitutions at position 12, which occupies the P10 pocket, Tyr and Phe were the preferred amino acids.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786680</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786681</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786682</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>17200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786683</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>22900.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Integrin b3-derived peptide analog</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAYSDQATLLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>AWCSDEALPLG</LinearSequence>
                            <StartingPosition>50</StartingPosition>
                            <EndingPosition>60</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P05106.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>TableS1</LocationOfData>
                <EpitopeId>135416</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is a synthetic peptide derived from the integrin β3 peptide, with positions 3, 6, 8, and 11 (anchor positions 1,4,6,and 9) changed to the corresponding residues from the influenza haemagglutinin peptide HA(306–318). Also Pro at position 9 is substituted with Leu.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3 and Table S1</LocationOfData>
                        <MhcBindingId>1769203</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>8300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786684</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>8100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>652</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786685</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>19800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>653</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786686</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>19300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>654</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5 and Table S4</LocationOfData>
                        <MhcBindingId>1786687</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>17700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>655</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

